1 Min Read
* Oncogenex Pharmaceuticals Inc reports financial results for third quarter 2016
* Qtrly loss per share $0.12
* Qtrly revenue $3.8 million versus $3.1 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.